中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2014年
29期
52-53
,共2页
云克%甲氨蝶呤%羟氯喹%类风湿关节炎
雲剋%甲氨蝶呤%羥氯喹%類風濕關節炎
운극%갑안접령%간록규%류풍습관절염
Yun Ke%Methotrexate%Hydroxychloroquine%Rheumatoid arthritis
目的：观察云克(99Tc-MDP)联合甲氨蝶呤、羟氯喹治疗类风湿关节炎的临床疗效。方法：2011年1月-2013年5月收治RA患者60例，随机分为两组，治疗组30例，对照组30例。治疗组为云克联合口服甲氨蝶呤、羟氯喹组，对照组为甲氨蝶呤+羟氯喹组，观察治疗前、治疗后第8周各项观察指标的变化。结果：治疗组的各项指标均较对照组有明显的改善，差异有统计学意义(P＜0.05)，而治疗中未发现有明显的不良反应。结论：云克联合甲氨蝶呤、羟氯喹治疗类风湿关节炎效果明显，耐受性好，值得推广。
目的：觀察雲剋(99Tc-MDP)聯閤甲氨蝶呤、羥氯喹治療類風濕關節炎的臨床療效。方法：2011年1月-2013年5月收治RA患者60例，隨機分為兩組，治療組30例，對照組30例。治療組為雲剋聯閤口服甲氨蝶呤、羥氯喹組，對照組為甲氨蝶呤+羥氯喹組，觀察治療前、治療後第8週各項觀察指標的變化。結果：治療組的各項指標均較對照組有明顯的改善，差異有統計學意義(P＜0.05)，而治療中未髮現有明顯的不良反應。結論：雲剋聯閤甲氨蝶呤、羥氯喹治療類風濕關節炎效果明顯，耐受性好，值得推廣。
목적：관찰운극(99Tc-MDP)연합갑안접령、간록규치료류풍습관절염적림상료효。방법：2011년1월-2013년5월수치RA환자60례，수궤분위량조，치료조30례，대조조30례。치료조위운극연합구복갑안접령、간록규조，대조조위갑안접령+간록규조，관찰치료전、치료후제8주각항관찰지표적변화。결과：치료조적각항지표균교대조조유명현적개선，차이유통계학의의(P＜0.05)，이치료중미발현유명현적불량반응。결론：운극연합갑안접령、간록규치료류풍습관절염효과명현，내수성호，치득추엄。
Objective:To observe the clinical effect of Yun Ke(99Tc-MDP) combined with methotrexate,hydroxychloroquine in the treatment of rheumatoid arthritis.Methods:60 cases of rheumatoid arthritis were selected from January 2011 to May 2013.They were divided into the treatment group and the control group with 30 cases in each.The treatment group was Yun Ke combined with oral methotrexate,hydroxychloroquine group.The control group was methotrexate and hydroxychloroquine group.Before treatment and 8 weeks after treatment,the changes of the observation indexes were observed.Results:The indexes of the treatment group were significantly improved than these of the control group;there was a statistically significant difference(P<0.05).There was no obvious adverse reaction in the treatment.Conclusion:Yun Ke(99Tc-MDP) combined with methotrexate,hydroxychloroquine in the treatment of rheumatoid arthritis have obvious effect and good tolerance.It is worthy of promotion.
